Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical Trial. [electronic resource]
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 02 2019
- 632-640 p. digital